TOBREX 2X

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

TOBRAMYCIN

متاح من:

NOVARTIS ISRAEL LTD

ATC رمز:

J01GB01

الشكل الصيدلاني:

EYE DROPS

تركيب:

TOBRAMYCIN 0.3 %

طريقة التعاطي:

OCULAR

نوع الوصفة الطبية :

Required

المصنعة من قبل:

ALCON CUSI S.A., SPAIN

المجموعة العلاجية:

TOBRAMYCIN

المجال العلاجي:

TOBRAMYCIN

الخصائص العلاجية:

Antibiotic for the treatment of superficial eye infections caused by bacteria sensitive to Tobramycin.

تاريخ الترخيص:

2012-05-31

نشرة المعلومات

PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
)PREPARATIONS(
– 1986
The medicine is dispensed
with a doctor’s prescription only
ESCITALOPRAM TEVA 10 MG
TABLETS
The active ingredient and its quantity:
Each tablet contains:
Escitalopram )as oxalate( 10 mg
ESCITALOPRAM TEVA 20 MG
TABLETS
The active ingredient and its quantity:
Each tablet contains:
Escitalopram )as oxalate( 20 mg
For information on the inactive ingredients,
see section 2 – “Important information about
some of the ingredients of the medicine”
and section 6 – “Further Information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the
medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed for you.
Do not pass it on to others. It may harm
them even if it seems to you that their
medical condition is similar.
This medicine is not usually intended for
use in children and adolescents under the
age of 18.
Antidepressants and anti-anxiety
medicines increase the risk of suicidal
behavior and thoughts in children,
adolescents and young adults up to the
age of 25.
Upon commencement of treatment
with the medicine, patients of all
ages, and their relatives, must monitor
behavioral changes, such as: worsening
of
depression,
suicidal
thoughts,
aggressiveness and the like.
If such changes occur, refer to a doctor
immediately.
1. WHAT IS THE MEDICINE INTENDED
FOR?
Escitalopram Teva is an antidepressant
from the selective serotonin reuptake
inhibitors )SSRI( group. Medicines
belonging to this group act on the serotonin
system in the brain by increasing serotonin
levels. Disruptions in the serotonin system
are considered important factors in
development of depression and diseases
associated with depression. Escitalopram
Teva
is
used
to
treat
the
following
conditions:
depression
panic disorders
generalized anxiety
social anxiety
obsessive-compulsive disorder
A few weeks may pass until you start to feel
bett

خصائص المنتج

TOB 2X API JAN22 V2
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT TOBREX 2X
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each mL of Tobrex 2X eye drops contains the active ingredient
tobramycin 3 mg in 1 mL.
Excipient with known effect
Preservative: Benzododecinium bromide (BDAB)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Eye drops.
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Antibiotic for the treatment of superficial eye infections caused by
bacteria sensitive to
Tobramycin.
4.2.
DOSE AND METHOD OF ADMINISTRATION
The dose is one drop of TOBREX 2X eye drops into the conjunctival sac
two times daily
(morning and evening) for 7±1 days.
If severe disease: on the first day, four instillations while awake.
Thereafter instill one
drop in each eye twice a day, while awake, until completion of the
7±1 days-total
treatment period.
To prevent contamination of the dropper tip and solution, care must be
taken not to
touch the eyelids, surrounding areas, or other surfaces with the
dropper tip of the
bottle. Keep the bottle tightly closed when not in use.
After cap is removed, if the tamper evident snap collar is loose,
remove before using
the product.
In case of concomitant therapy with other topical ocular medicines, an
interval of 5-10
minutes should be allowed between successive applications.
_Use in elderly _
No dosage adjustment in elderly patients is necessary.
_Paediatric Population _
TOBREX 2X eye drops may be used in children 1 year of age and older at
the same dose
as in adults. The safety and efficacy in children younger than 1 year
of age have not
been established, and no data are available.
TOB 2X API JAN22 V2
_ _
_Use in hepatic and renal impairment _
Ocular application of tobramycin gives very little systemic exposure.
In case of
concomitantly administered systemic treatment with aminoglycoside
antibiotics, care
should be taken to monitor the total serum concentration in order to
ensure that an
appropriate therapeutic level is maintained.
4.3.
CONTR